TrialTrials2017

Allogeneic mesenchymal stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation: study protocol for a randomized controlled trial.

Qipeng Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.